Ambiguity and misinformation on Italian hemp decree spread yet more confusion

A recent agreement to update the Italian list of officinal (medically usable) plants has caused some unfounded consternation in the country’s CBD industry.

The Italian Agriculture Ministry and the ministries of Health and Ecological Transition, along with the State-Regions Conference, reached an agreement to include hemp seeds and their by-products on the list – but at the same time inserting cannabis flowers, leaves or “active substances” (cannabinoids) destined for medical purposes under the regulatory framework of Narcotics Law n.309/90.

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

VIEW REPORTS

Request a free sample of this report:

“ Ambiguity and misinformation on Italian hemp decree spread yet more confusion ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ Ambiguity and misinformation on Italian hemp decree spread yet more confusion ”






      A recent agreement to update the Italian list of officinal (medically usable) plants has caused some unfounded consternation in the country’s CBD industry.

      The Italian Agriculture Ministry and the ministries of Health and Ecological Transition, along with the State-Regions Conference, reached an agreement to include hemp seeds and their by-products on the list – but at the same time inserting cannabis flowers, leaves or “active substances” (cannabinoids) destined for medical purposes under the regulatory framework of Narcotics Law n.309/90.

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik